Pan American Health Organization, 2005. Control of Yellow Fever: Field Guide. Washington, DC: Pan American Health Organization.

Pan American Health Organization, 2005. Control of Yellow Fever: Field Guide. Washington, DC: Pan American Health Organization.)| false
• Search Google Scholar
• Export Citation

Pan American Health Organization, 2008. Outbreak of yellow fever in Paraguay. PAHO Epidemiol Bull 27: 1–7.

Pan American Health Organization, 2008. Outbreak of yellow fever in Paraguay. PAHO Epidemiol Bull 27: 1–7.)| false
• Search Google Scholar
• Export Citation

Pan American Health Organization, 2008. Final Statement by the Pan American Health Organization/World Health Organization (PAHO/WHO) on Investigation of Serious Adverse Events in Peru following Receipt of Yellow Fever Vaccine Produced by Bio-Manguinhos, Brazil. Posted March 21, 2008 [cited 2009 Apr 23]. Available at: http://www.paho.org/English/AD/DPC/CD/eid-eer-2008-03-27htm.

Pan American Health Organization, 2008. Final Statement by the Pan American Health Organization/World Health Organization (PAHO/WHO) on Investigation of Serious Adverse Events in Peru following Receipt of Yellow Fever Vaccine Produced by Bio-Manguinhos, Brazil. Posted March 21, 2008 [cited 2009 Apr 23]. Available at: http://www.paho.org/English/AD/DPC/CD/eid-eer-2008-03-27htm.)| false
• Search Google Scholar
• Export Citation

Barnett ED, 2007. Yellow fever: epidemiology and prevention. Clin Infect Dis 44: 850–856.

BarnettED, 2007. Yellow fever: epidemiology and prevention. Clin Infect Dis 44: 850–856.)| false
• Search Google Scholar
• Export Citation

Martin M, Tsai TF, Cropp B, Chang GJ, Holmes DA, Tseng J, Shieh W, Zaki SR, Al-Sanouri I, Cutrona AF, Ray G, Weld LH, Cetron MS, 2001. Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. Lancet 358: 98–104.

MartinMTsaiTFCroppBChangGJHolmesDATsengJShiehWZakiSRAl-SanouriICutronaAFRayGWeldLHCetronMS, 2001. Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. Lancet 358: 98–104.)| false
• Search Google Scholar
• Export Citation

2002. Adverse events associated with 17D-derived yellow fever vaccination–United States, 2001–2002. MMWR Morb Mortal Wkly Rep 51: 989–993.

2002. Adverse events associated with 17D-derived yellow fever vaccination–United States, 2001–2002. MMWR Morb Mortal Wkly Rep 51: 989–993.)| false
• Search Google Scholar
• Export Citation

Engel AR, Vasconcelos PF, McArthur MA, Barrett AD, 2006. Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil. Vaccine 24: 2803–2809.

EngelARVasconcelosPFMcArthurMABarrettAD, 2006. Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil. Vaccine 24: 2803–2809.)| false
• Search Google Scholar
• Export Citation

Centers for Disease Control and Prevention, 2002. Adverse events associated with 17D-derived yellow fever vaccination–United States, 2001–2002. MMWR Morb Mortal Wkly Rep 51: 989–993.

Centers for Disease Control and Prevention, 2002. Adverse events associated with 17D-derived yellow fever vaccination–United States, 2001–2002. MMWR Morb Mortal Wkly Rep 51: 989–993.)| false
• Search Google Scholar
• Export Citation

Bae HG, Domingo C, Tenorio A, de Ory F, Munoz J, Weber P, Teuwen DE, Niedrig M, 2008. Immune response during adverse events after 17D-derived yellow fever vaccination in Europe. J Infect Dis 197: 1577–1584.

BaeHGDomingoCTenorioAde OryFMunozJWeberPTeuwenDENiedrigM, 2008. Immune response during adverse events after 17D-derived yellow fever vaccination in Europe. J Infect Dis 197: 1577–1584.)| false
• Search Google Scholar
• Export Citation

Munoz J, Vilella A, Domingo C, Nicolas JM, de Ory F, Corachan M, Tenorio J, Gascon J, 2008. Yellow fever-associated viscerotropic disease in Barcelona, Spain. J Travel Med 15: 202–205.

MunozJVilellaADomingoCNicolasJMde OryFCorachanMTenorioJGasconJ, 2008. Yellow fever-associated viscerotropic disease in Barcelona, Spain. J Travel Med 15: 202–205.)| false
• Search Google Scholar
• Export Citation

Engel AR, Vasconcelos PF, McArthur MA, Barrett AD, 2006. Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil. Vaccine 24: 2803–2809.

EngelARVasconcelosPFMcArthurMABarrettAD, 2006. Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil. Vaccine 24: 2803–2809.)| false
• Search Google Scholar
• Export Citation

Martin M, Weld LH, Tsai TF, Mootrey GT, Chen RT, Niu M, Cetron MSGeoSentinel Yellow Fever Working Group, 2001. Advanced age a risk factor for illness temporally associated with yellow fever vaccination. Emerg Infect Dis 7: 945–951.

MartinMWeldLHTsaiTFMootreyGTChenRTNiuMCetronMSGeoSentinel Yellow Fever Working Group, 2001. Advanced age a risk factor for illness temporally associated with yellow fever vaccination. Emerg Infect Dis 7: 945–951.)| false
• Search Google Scholar
• Export Citation

Lindsey NP, Schroeder BA, Miller ER, Braun MM, Hinckley AF, Marano N, Slade BA, Barnett ED, Brunette GW, Horan K, Staples JE, Kozarsky PE, Hayes EB, 2008. Adverse event reports following yellow fever vaccination. Vaccine 26: 6077–6082.

LindseyNPSchroederBAMillerERBraunMMHinckleyAFMaranoNSladeBABarnettEDBrunetteGWHoranKStaplesJEKozarskyPEHayesEB, 2008. Adverse event reports following yellow fever vaccination. Vaccine 26: 6077–6082.)| false
• Search Google Scholar
• Export Citation

Whittembury A, Ramirez G, Hernandez H, Ropero AM, Waterman S, Ticona M, Brinton M, Uchuya J, Gershman M, Toledo W, Staples E, Campos C, Martinez M, Chang GJ, Cabezas C, Lanciotti R, Zaki S, Montgomery JM, Monath T, Hayes EMinisterio de Salud, Lima, Peru, 2009. Viscerotropic disease following yellow fever vaccination in Peru. Vaccine 27: 5974–5981.

WhittemburyARamirezGHernandezHRoperoAMWatermanSTiconaMBrintonMUchuyaJGershmanMToledoWStaplesECamposCMartinezMChangGJCabezasCLanciottiRZakiSMontgomeryJMMonathTHayesEMinisterio de Salud, Lima, Peru, 2009. Viscerotropic disease following yellow fever vaccination in Peru. Vaccine 27: 5974–5981.)| false
• Search Google Scholar
• Export Citation

Monath TP, Cetron MS, 2002. Prevention of yellow fever in persons traveling to the tropics. Clin Infect Dis 34: 1369–1378.

MonathTPCetronMS, 2002. Prevention of yellow fever in persons traveling to the tropics. Clin Infect Dis 34: 1369–1378.)| false
• Search Google Scholar
• Export Citation

Wilder-Smith A, Hill DR, Freedman DO, 2008. The revised International Health Regulations (2005): impact on yellow fever vaccination in clinical practice. Am J Trop Med Hyg 78: 359–360.

Wilder-SmithAHillDRFreedmanDO, 2008. The revised International Health Regulations (2005): impact on yellow fever vaccination in clinical practice. Am J Trop Med Hyg 78: 359–360.)| false
• Search Google Scholar
• Export Citation

Monath TP, 2007. Dengue and yellow fever–challenges for the development and use of vaccines. N Engl J Med 357: 2222–2225.

MonathTP, 2007. Dengue and yellow fever–challenges for the development and use of vaccines. N Engl J Med 357: 2222–2225.)| false
• Search Google Scholar
• Export Citation

Kramer LD, Li J, Shi PY, 2007. West Nile virus. Lancet Neurol 6: 171–181.

KramerLDLiJShiPY, 2007. West Nile virus. Lancet Neurol 6: 171–181.)| false
• Search Google Scholar
• Export Citation